Home / SHIEF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SHIEF make money? Does SHIEF have pricing power? What's the Earnings Whisper? Will SHIEF profit more as the business scales? What is SHIEF's management track record? Is SHIEF's current price justified?

Shield Therapeutics plc

$0.09 -$0.06 (-41.37%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.09

Day Range

$0.06$0.09

Year Range

$0.05$0.17

Market Cap

91.55M

AVG Volume

29.15K

Trailing/Forward PE

-6.4/16.49

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Free Cash Flow Yield

SHIEF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-8.94%
Sep 26	-8.94%
Aug 26	-8.94%
Aug 26	-10.87%
Aug 26	-10.87%
Aug 26	-13.72%
Jul 26	-13.2%
Jul 26	-10.05%
Jul 26	-9.65%
Jul 26	-9.65%
Jul 26	-9.57%
Jun 26	-9.57%
Jun 26	-9.57%
Jun 26	-9.57%
Jun 26	-9.57%
May 26	-9.57%
May 26	-8.11%
May 26	-6.37%
May 26	-6.77%
May 26	-4.56%
Apr 26	-4.56%
Apr 26	-6.08%
Apr 26	-6.08%
Apr 26	-7.13%
Mar 26	-3.64%
Mar 26	-2.76%
Mar 26	-2.76%
Mar 26	-2.76%
Feb 26	-2.76%
Feb 26	-2.76%
Feb 26	-2.62%
Feb 26	-2.58%
Jan 26	-2.79%
Jan 26	-2.6%
Jan 26	-2.65%
Jan 26	-2.65%
Jan 26	-2.67%
Dec 25	-2.9%
Dec 25	-4.33%
Dec 25	-4.33%
Dec 25	-4.33%
Nov 25	-4.33%
Nov 25	-4.33%
Nov 25	-4.26%
Nov 25	-3.97%
Oct 25	-3.97%
Oct 25	-4%
Oct 25	-4%
Oct 25	-4%
Oct 25	-4%
Sep 25	-28.35%
Sep 25	-28.35%
Sep 25	-24.64%
Sep 25	-27.52%
Aug 25	-27.52%
Aug 25	-26.09%
Aug 25	-74.8%
Aug 25	-74.8%
Aug 25	-74.8%
Jul 25	-74.8%
Jul 25	-74.8%
Jul 25	-74.8%
Jul 25	-74.8%
Jun 25	-74.8%
Jun 25	-83.24%
Jun 25	-83.24%
Jun 25	-87.01%
May 25	-84.71%
May 25	-84.71%
May 25	-84.71%
May 25	-84.71%
May 25	-84.71%
Apr 25	-84.71%
Apr 25	-84.71%
Apr 25	-84.71%
Apr 25	-84.71%
Mar 25	-115.62%
Mar 25	-115.62%
Mar 25	-115.62%
Mar 25	-115.62%
Feb 25	-115.62%
Feb 25	-115.62%
Feb 25	-115.62%
Feb 25	-115.62%
Jan 25	-115.62%
Jan 25	-113.94%
Jan 25	-113.94%
Jan 25	-113.94%
Jan 25	-113.94%
Dec 24	-113.94%
Dec 24	-110.73%
Dec 24	-110.73%
Dec 24	-107.4%
Nov 24	-107.4%
Nov 24	-107.4%
Nov 24	-107.4%
Nov 24	-107.4%
Nov 24	-64.02%
Oct 24	-64.02%
Oct 24	-64.02%

Price to Sales

SHIEF Price to Sales by year
Period	Price to Sales
Sep 26	1.4
Sep 26	1.4
Aug 26	1.4
Aug 26	1.15
Aug 26	1.15
Aug 26	0.91
Jul 26	0.95
Jul 26	1.24
Jul 26	1.29
Jul 26	1.29
Jul 26	1.31
Jun 26	1.31
Jun 26	1.31
Jun 26	1.31
Jun 26	1.31
May 26	1.31
May 26	1.54
May 26	1.96
May 26	1.84
May 26	2.74
Apr 26	2.74
Apr 26	2.06
Apr 26	2.06
Apr 26	1.75
Mar 26	2.45
Mar 26	3.22
Mar 26	3.22
Mar 26	3.22
Feb 26	3.22
Feb 26	3.22
Feb 26	3.4
Feb 26	3.45
Jan 26	3.19
Jan 26	3.42
Jan 26	3.36
Jan 26	3.36
Jan 26	3.33
Dec 25	3.07
Dec 25	2.06
Dec 25	2.06
Dec 25	2.06
Nov 25	2.06
Nov 25	2.06
Nov 25	2.09
Nov 25	2.24
Oct 25	2.24
Oct 25	2.23
Oct 25	2.23
Oct 25	2.23
Oct 25	2.23
Sep 25	3
Sep 25	3
Sep 25	3.45
Sep 25	3.09
Aug 25	3.09
Aug 25	3.25
Aug 25	1.13
Aug 25	1.13
Aug 25	1.13
Jul 25	1.13
Jul 25	1.13
Jul 25	1.13
Jul 25	1.13
Jun 25	1.13
Jun 25	1.02
Jun 25	1.02
Jun 25	0.98
May 25	1
May 25	1
May 25	1
May 25	1
May 25	1
Apr 25	1
Apr 25	1
Apr 25	1
Apr 25	1
Mar 25	1.35
Mar 25	1.35
Mar 25	1.35
Mar 25	1.35
Feb 25	1.35
Feb 25	1.35
Feb 25	1.35
Feb 25	1.35
Jan 25	1.35
Jan 25	1.37
Jan 25	1.37
Jan 25	1.37
Jan 25	1.37
Dec 24	1.37
Dec 24	1.41
Dec 24	1.41
Dec 24	1.46
Nov 24	1.46
Nov 24	1.46
Nov 24	1.46
Nov 24	1.46
Nov 24	2.45
Oct 24	2.45
Oct 24	2.45

Price/Operating Cashflow

SHIEF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Mar 21	14.87
Mar 21	14.79
Mar 21	14.73
Mar 21	35.11
Feb 21	34.88
Feb 21	34.66
Feb 21	35.05
Feb 21	35.35
Jan 21	35.44
Jan 21	35.07
Jan 21	35.32
Jan 21	35.39
Dec 20	35.13
Dec 20	35.43
Dec 20	35.47
Dec 20	36.28
Dec 20	35.72
Nov 20	36.04
Nov 20	36.11
Nov 20	36.36
Nov 20	36.5
Oct 20	37.06
Oct 20	36.79
Oct 20	37.18
Oct 20	36.79
Oct 20	37.09

Price to Book

SHIEF Price to Book by year
Period	Price to Book
Mar 25	49.09
Mar 25	49.09
Mar 25	49.09
Mar 25	49.09
Feb 25	49.09
Feb 25	49.09
Feb 25	49.09
Feb 25	49.09
Jan 25	49.09
Jan 25	49.81
Jan 25	49.81
Jan 25	49.81
Jan 25	49.81
Dec 24	49.81
Dec 24	51.26
Dec 24	51.26
Dec 24	52.85
Nov 24	52.85
Nov 24	52.85
Nov 24	52.85
Nov 24	52.85
Nov 24	88.65
Oct 24	88.65
Oct 24	88.65
Oct 24	79.41
Oct 24	76.52
Sep 24	2.62
Sep 24	2.97
Sep 24	2.97
Sep 24	2.97
Aug 24	1.09
Aug 24	1.09
Aug 24	1.09
Aug 24	1.09
Aug 24	1.09
Jul 24	1.09
Jun 24	1.09
May 24	0.89
May 24	1.09
Apr 24	0.95
Apr 24	0.99
Mar 24	0.51
Mar 24	0.55
Mar 24	0.61
Mar 24	0.59
Feb 24	0.9
Feb 24	1.71
Jan 24	1.71
Jan 24	1.71
Dec 23	1.71
Dec 23	1.71
Dec 23	1.71
Dec 23	1.31
Dec 23	1.47
Nov 23	1.47
Nov 23	1.47
Nov 23	1.47
Nov 23	1.52
Oct 23	1.52
Oct 23	1.52
Oct 23	2.05
Oct 23	2.05
Sep 23	2.05
Sep 23	5.08
Sep 23	5.04
Sep 23	5.38
Sep 23	4.65
Aug 23	4.94
Aug 23	4.88
Aug 23	4.97
Aug 23	5.12
Jul 23	4.32
Jul 23	4.44
Jul 23	3.05
May 23	3.22
May 23	3.21
May 23	3.5
May 23	3.45
Apr 23	3.29
Apr 23	2.73
Apr 23	2.74
Apr 23	2.61
Mar 23	2.63
Mar 23	0.41
Mar 23	0.41
Mar 23	0.56
Mar 23	0.56
Feb 23	0.57
Feb 23	0.56
Feb 23	0.5
Feb 23	0.46
Jan 23	0.44
Jan 23	0.44
Jan 23	0.45
Jan 23	0.45
Dec 22	0.45
Dec 22	0.5
Dec 22	0.49
Dec 22	0.64
Dec 22	0.64

No video analysis for this stock yet. Request one from our team.

News: SHIEF

seekingalpha.com · 1 Sep 2026

Shield Therapeutics plc (SHIEF) Discusses Strategic Acquisition of Full U.S. Commercial Control of ACCRUFeR Transcript

proactiveinvestors.co.uk · 28 Aug 2026

Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris

Cavendish has reiterated its buy rating on Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) following the pharmaceutical company's agreement to take full commercial control of its main United States (US) product from Viatris. The broker kept its target price at 23 pence, implying potential upside of 318% from current share price of about 5.5 pence.

proactiveinvestors.co.uk · 20 Aug 2026

Shield Therapeutics jumps 11% as losses narrow and profitability target held

Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) rose 11% to 4.89p on Thursday after the pharmaceutical company reported sharply narrower half-year losses and reaffirmed its aim of reaching operating profitability in 2026. Peel Hunt reiterated its 'buy' rating and 15p price target, describing the first-half results as in line and the business as on track for profitability this year.

seekingalpha.com · 30 Jul 2026

Shield Therapeutics plc (SHIEF) Q2 2026 Sales/Trading Call Transcript

proactiveinvestors.co.uk · 30 Jul 2026

Shield Therapeutics shares slip after interims, small-cap pharma says its still 'on-track'

Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) told investors it remained profitable in the first half as a China milestone payment and higher royalties lifted revenue 41% to $30.4 million, with the company reiterating that it is on track for profitability in 2026. The $7.9 million development payment from partner ASK offset softer second-quarter trading.